Sugi Predict

Sugi Predict / Compounds / SCHEMBL22968445

SCHEMBL22968445

SCHEMBL22968445

Cc1nc2nonc2c(N)c1CN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.57

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MBOAT4 Q96T53 17/20 0.57
▸ TLR8 Q9NR97 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21230057 0.88 MBOAT4 (0.57) MBOAT4KDM4EALDH1A1LMNAHPGD
SCHEMBL21222820 0.85 MBOAT4 (0.57) MBOAT4KDM4EALDH1A1LMNAHPGD
SCHEMBL21223048 0.83 MBOAT4 (0.61) MBOAT4KDM4EALDH1A1LMNAHPGD
SCHEMBL21230215 0.81 MBOAT4 (0.59) MBOAT4KDM4EALDH1A1LMNAHPGD
SCHEMBL208417 0.76 TLR8 (0.47) TLR8KDM4EALDH1A1LMNAKMT2A
SCHEMBL21230106 0.76 MBOAT4 (0.57) MBOAT4KDM4EALDH1A1LMNAHPGD
SCHEMBL21230088 0.75 MBOAT4 (0.61) MBOAT4
SCHEMBL21230107 0.74 MBOAT4 (0.61) MBOAT4
Hydrochloric Acid SCHEMBL21222969 0.74 MBOAT4 (0.60) MBOAT4
SCHEMBL21230099 0.73 MBOAT4 (0.62) MBOAT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655699-B Heterocyclyl-substituted oxadiazolopyridine derivatives useful as ghrelin O-acyltransferase (GOAT) inhibitors 勃林格殷格翰国际有限公司 2023-07-14 — — CN disclosed
US-11319310-B2 Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-03 — — US disclosed
US-11319310-B2 Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-03 — — US disclosed
EP-3746450-B1 HETEROCYCLYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2022-03-16 — — EP disclosed
US-20210040077-A1 HETEROCYCLYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2021-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319310-B2 Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors MBOAT4, NPY1R, GIPR MBOAT4 1/4885TLR8 3950/4885KDM4E 2040/4885
US-20210040077-A1 HETEROCYCLYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS MBOAT4, NPY1R, GIPR MBOAT4 1/4885TLR8 3950/4885KDM4E 2040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.